Prostate Cancer Treatment
Many options may be considered
Treatment
varies from person to person.
Age, overall health, stage and grade of tumor, and PSA levels all factor into a
prostate cancer treatment plan.
For a man with advanced prostate cancer, many strategies may be used to treat the
cancer.All treatment options can cause side effects, some life-threatening. All
treatment options and risks should be discussed with your healthcare team.
This Web page provides information on the most common ways of treating prostate
cancer. Work with your doctor and the other members of your healthcare team to create
the treatment plan that's right for you.
Learn more about a specific treatment:
Surgery
Surgery is a common treatment for early-stage cancer.
When a cancer is confined to the actual prostate gland, or localized (it is stage
I or II and has a low Gleason score), surgery is often recommended. It may also
be recommended for younger men who are in good health.
One common type of prostate cancer surgery is called a radical prostatectomy.
During a radical prostatectomy, a surgeon removes the entire prostate gland and
sometimes the nearby lymph nodes, along with the seminal vesicles
and other surrounding tissues. “Nerve-sparing” radical prostatectomies leave intact
the nerves to the penis that control erections.
Another type of prostate cancer surgery is cryosurgery.
Cryosurgery, also called cryotherapy, is a relatively new technique which uses very
cold gasses to freeze and destroy the prostate. Cryosurgery also often comes with
side effects, such as incontinence and impotence.
Radiation
Radiation therapy uses X-rays to kill cancer cells.
Using high-energy X-rays, emitted either by a machine or by implanted radioactive
“seeds,” radiation therapy kills cancer cells in the prostate. Radiation therapy
sometimes serves as an alternative to surgery, or it may be used after surgery to
kill any remaining cancer cells.
The types of radiation therapy are external beam radiation and brachytherapy
(“seed” implantation).
Cellular immunotherapy
Cellular immunotherapy is used to treat advanced prostate cancer that is no longer
responding to hormone therapy. It is thought to work by helping the body’s own immune
system identify and attack prostate cancer cells.
One example of cellular immunotherapy is obtained by a patient’s immune cells from the blood, and then using a machine in a process known as leukapheresis.
To enhance their response against the cancer, the immune cells are then exposed
to a protein that is found in most prostate cancers, linked to an immune-stimulating
substance. After this process, the patient’s own cells are returned to the patient
to treat the prostate cancer.
This treatment is given as a series of 3 infusions into a vein, with about 2 weeks
between each infusion.
Hormone therapy
For advanced prostate cancers, treatments that target the whole body are used.
Hormone therapy may slow the advance of a tumor by shrinking it. Hormone therapy
may be given before surgery or radiation therapy. And sometimes hormone therapy
is used after surgery or radiation therapy to prevent prostate cancer from coming
back.
Because hormones are found throughout the body, hormone therapy can fight cancers
that have spread beyond the prostate gland. Hormone therapy cannot cure prostate
cancer, but, for some men, it can stop the disease from getting worse.
Hormone therapy targets testosterone.
Hormone therapy targets prostate cancer by cutting off the male hormones
(called androgens), which make prostate cancer grow. The main androgen
is testosterone, produced in the testes. Testosterone is usually
the target of hormone therapy.
To reduce the amount of testosterone in the body, the testicles can be removed surgically
(this is called orchiectomy or castration), or medications can
be used.
Hormone drugs can cut off the supply of testosterone.
Here are some of the types of hormone drugs used to treat prostate cancer:
- Luteinizing hormone-releasing hormone (LHRH) analogs. These medicines
lower the amount of androgens that the testicles produce. LHRH analogs are the most
common drugs used for lowering the levels of testosterone in the body
- Female hormones (estrogens). These block the release of testosterone.
- Antiandrogens. These block the activity of androgens
When hormones fail to stop the spread of prostate cancer, it is classified as hormone
refractory. The next step is usually treatment with chemotherapy.
Chemotherapy
As a cancer spreads, chemotherapy is another treatment option.
Chemotherapy, or “chemo,” is a systemic treatment, meaning it can fight
cancer throughout the body. Chemotherapy may be given orally (through the mouth)
or by infusion (using an IV).
Chemotherapy is often used to treat advanced prostate cancer if hormone therapy
is no longer working. Chemo may shrink a tumor or stop it from spreading, and can
affect cancer at different sites in the body.
Chemotherapy may be used as a form of palliative therapy to try to relieve symptoms
caused by the cancer, such as pain, or problems with breathing and swallowing.
The multidisciplinary team
Each man fighting prostate cancer is going to have a different experience.
So it's important that you talk to your whole healthcare team, or multidisciplinary
team—meaning a group of doctors with different specialties. This team can include:
- Your primary physician
- A urologist, or doctor who specializes in diseases of the urinary system
and male reproductive system
IMPORTANT SAFETY INFORMATION FOR JEVTANA® (CABAZITAXEL) INJECTION
WARNING
JEVTANA may cause serious side effects, including low white blood cells. Low
white blood cells can cause you to get serious infections, and may lead to death.
The earliest sign of infection may be fever, so tell your doctor right away if you
have a fever. People who are 65 years or older may be more likely to have these
problems. JEVTANA should not be given to patients with low white blood cell counts.
Your doctor:
- Will do blood tests regularly to check your white blood cell counts during
your treatment with JEVTANA
- May lower your dose of JEVTANA, change how often you receive it, or stop
JEVTANA until you have enough white blood cells
- May prescribe a medicine for you to help prevent complications if your white
blood cell count is too low
JEVTANA can also cause severe allergic reactions. Severe allergic reactions
can happen within a few minutes after your infusion of JEVTANA starts, especially
during the first and second infusions. Your doctor should prescribe medicines before
each infusion to help prevent severe allergic reactions.
- Symptoms of severe allergic reactions may include rash or itching, skin
redness, feeling dizzy or faint, breathing problems, chest or throat tightness,
swelling of face. Tell your doctor right away if you have any of these symptoms.
Your doctor will stop your JEVTANA treatment right away and treat your allergic
reaction.
You should not take JEVTANA if you have had a severe allergic reaction to JEVTANA
or other medicines that contain polysorbate 80. Ask your doctor if you are not sure.
JEVTANA can also cause gastrointestinal symptoms.
Nausea, vomiting and diarrhea can happen when you take JEVTANA. Severe vomiting
and diarrhea with JEVTANA can lead to loss of too much body fluid (dehydration),
or too much of your body salts (electrolytes). Death has happened from having severe
diarrhea and losing too much body fluid or body salts with JEVTANA. Tell your doctor
if you have vomiting or diarrhea. Your doctor will prescribe medicines to prevent
or treat vomiting and diarrhea, as needed with JEVTANA. You may need to go to the
hospital for treatment.
Kidney failure may happen with JEVTANA.
Kidney failure may happen because of severe infection, loss of too much body fluid
(dehydration), or for other reasons, which may lead to death. Your doctor will check
you for this problem and treat you if needed. Tell your doctor if you develop:
- Swelling of your face or body
- Decrease in the amount of urine that your body makes each day
Before receiving JEVTANA, tell your doctor if you:
- had allergic reactions in the past
- have kidney or liver problems. JEVTANA should not be given to patients with liver
problems (hepatic impairment)
- are age 65 or older as these patients:
-
— may be more likely to experience certain adverse reactions, including low
white blood cell count
with or without fever, tiredness, weakness, fever,
dizziness, urinary tract infection and
dehydration
- have any other medical conditions
- if you are female and:
- — are pregnant or plan to become pregnant as JEVTANA can harm your unborn
baby
- — are breastfeeding or plan to breastfeed
Serious side effects of JEVTANA include low white blood cell counts
that could lead to serious or life-threatening infections, severe allergic reactions,
gastrointestinal symptoms (nausea, severe vomiting and diarrhea) that could lead
to death, and kidney failure.
Common side effects of JEVTANA include:
- Low white blood cell count
- Low red blood cell count (anemia). Symptoms of anemia include shortness
of breath and tiredness
- Low blood platelet count. Tell your doctor if you have any unusual
bruising or bleeding
- Tiredness
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Weakness
|
|
- Blood in the urine
- Back pain
- Decreased appetite
- Fever
- Shortness of breath
- Stomach (abdominal) pain
- Change in your sense of taste
- Cough
- Joint pain
- Hair loss
- Numbness, tingling, burning or decreased sensation in your hands or feet
|
Tell your doctor if you have any side effect that bothers you or that does not go
away. These are not all the possible side effects of JEVTANA. For more information,
ask your doctor or pharmacist. You may report side effects to FDA at
1-800-FDA-1088.
Remember, your doctor is the single best source of information regarding your
health. Please consult your doctor if you have any questions about your health or
your medicine.
For more information, go to www.sanofi.us
or call 1-800-633-1610.
See
Full Prescribing Information including Boxed WARNING.